Vasculitis
Rheumatology Round-Up with Drs. Kavanaugh & Cush
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.
Mavrilimumab in Giant Cell Arteritis: Dr. Richard Conway
Dr. Conway discusses late-breaking abstract #L06 presented Monday at the ACR 2020 annual meeting.
GCA Treatment Data: Dr. David Liew Abstract
Dr. David Liew reviews abstracts #0516 and #0513 presented at the 2020 ACR annual meeting.
Imaging and Large Vessel Vasculitis: Dr. Alexa S. Meara interviews Dr. Kaitlin Quinn
Dr. Alexa Meara interviews Dr. Kaitlin Quinn about studies looking at large vessel vasculitis and new imaging techniques (abstracts #0428, #0514 and #1922) at the 2020 ACR annual meeting.
Long-Term Prognosis in Children with Kawasaki Disease: Dr. David Liew
Dr. David Liew reviews abstract #0937 presented at the 2020 ACR annual meeting.
Avacopan - C5a Receptor Inhibitor - in ANCA-Associated Vasculitis: Dr. Arthur Kavanaugh
San Diego-based rheumatologist Dr. Arthur Kavanaugh takes a closer look at plenary session Abstract #0432 presented Friday at ACR 2020.
Pearls for Navigating ACR 2020: Drs. Meral El Ramahi and Kevin Byram
In this video, Dr. El Ramahi talks with Dr. Kevin Byram, on his thoughts about maximizing participation in ACR, vasculitis and other sessions he is interested in attending, and what abstracts he is excited to see presented.
Poster Hall